Cuffe Michael S. has filed a Form 144 to sell 11,800 shares of HCA Healthcare, Inc. This filing is significant as it indicates a substantial transaction involving shares acquired through performance awards. The move underscores the ongoing activity within the healthcare sector, particularly among executives managing their equity stakes.
Background
Cuffe Michael S. is an officer at HCA Healthcare, Inc., a company classified under the SIC description for services in general medical and surgical hospitals. The company operates primarily in the healthcare industry, providing a range of medical services. HCA Healthcare is publicly traded under the ticker symbol HCA on the New York Stock Exchange.
What the Filing Says
The filing, dated October 29, 2026, details that Cuffe is selling these shares at an aggregate market value of approximately $5,628,600. The shares were acquired through various performance awards, with the most recent acquisition on the same date as the filing. The filing states, "Michael S Cuffe is selling 11,800 shares of common stock of HCA Healthcare, Inc." This transaction reflects Cuffe's ongoing management of his equity position within the company.
Impact
This transaction may affect various stakeholders, including HCA Healthcare's investors and employees. As Cuffe is an officer, his actions may be closely scrutinized by shareholders and analysts who monitor executive compensation and stock sales. The filing indicates that Cuffe's shares were acquired through performance awards, which may signal a strong performance by the company and its executives.
What's Next
The filing does not say what happens next regarding Cuffe's remaining shares or any future plans for additional transactions.
Read Next
Wells Fargo files preliminary pricing for new notes issuance
GS Finance Corp. Files Pricing Supplement for New Notes
GS Finance Corp. files for new index-linked notes
Wells Fargo issues $3.12 billion in Medium-Term Notes
BioAtla files prospectus for resale of 8.1 million shares
PLC Neurotech Fund I LP Files New Offering Under SEC Rules








